Latest clinical trials News | Page 40

Cancer Therapeutics CRC/Canthera Discovery next generation drugs land CRA Award for Research Commercialisation
New strategy to preserve insulin-producing cells in diabetes
Researchers honoured with NHMRC leadership awards
Study shows long-term safety of genetically modified immune effector cells
Two distinct tuberculosis subtypes IDed – implications for personalized therapy
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
Best statins for reducing cardiovascular risk in people with diabetes found
Study reveals structure of anti-tumor therapy’s target
Vaxine Pty Ltd fined $13,320 for alleged unlawful advertising of an unapproved Covid vaccine
Large molecule facility doubles size of leading bioanalytical laboratory
Partnership secures Australian-made mRNA vaccines
Researchers lead human trials for malaria vaccine
Blood sample trial to help determine next flu vaccine
New insights on COVID-associated blood clots in people with inherited thrombotic conditions
Potential new Covid immunotherapy could protect vulnerable
Victoria And Abu Dhabi Sign Research And Investment Partnership
Australia and Korea sign MoU on vaccine research
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
Backing life-saving local cancer drug development
Better care and treatment for Australians with blood cancer
AI Biotech Lands In Victoria To Advance Early Cancer Detection
New mathematical model predicts effectiveness of Covid vaccines
Boost to funding for R&D trials to find treatments for MND
Many Australian medical researchers not declaring conflicts of interest: Study
Victoria Secures Partnership With Korea On Vaccine Research
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Rebrand for Australia’s largest life sciences venture fund
Support for you and your family through pancreatic cancer
Interim Statement on Covid vaccines in context of circulation of Omicron SARS-CoV-2 Variant from WHO Technical Advisory Group 8 March
Cell-based Flucelvax Quad influenza vaccine now approved for Australian children aged two years and older
Covid vaccine rollout worsened existing health inequalities, find researchers
Discovery may help reduce side effects of MS drugs
Evenings with Genetics: new therapies for genetic conditions
Transforming our mental health through nutrition
In Memory of Emeritus Professor Pamela Russell AM
Funding support for early detection of Parkinson’s disease
Vaping: An examination of facts
AusBiotech highlights clarity and transparency is key in recent submissions
Workplace activity programs can help with stress, anxiety and sleep
Are medicines affecting our response to infections like Covid?
Phebra Receives TGA Authorisation for Manufacture of Critical Care Medicines for TGA Trials
BeiGene hits Major Milestone with First PBS Approved Cancer Treatment
Rare cancer treatment approved by Pharmaceutical Benefits Scheme
New low-cost dialysis system can make medical grade water in home, giving green light to progress to clinical trials
Covid clinical trials disproportionately run out of high-income countries research shows
Trialling non-invasive liver cancer treatment
Cancer Council funds ground-breaking research into aggressive childhood cancers
TGA provisionally approves AstraZeneca’s combination therapy – for pre-exposure prevention of Covid